AIM ImmunoTech Inc.

AIMAMEXHealthcare● Active

$0.54

+$0.02(+3.82%)

Market Cap$1822596

P/E Ratio—

52W High$19.73812

52W Low$0.21

Avg Volume27.4M

Open$0.62

Beta1.24

Overview

AIM ImmunoTech Inc. (AIM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AIM · as of Mar 27, 2026

Latest filing snapshot

-2-9.52%vs prior year

AIM ImmunoTech Inc. (AIM) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-2

Growth % (1Y)

-9.52%

Revenue / Employee

$4.6K

Net Income / Employee

$-734.6K

Market Cap

$2M

AIM Employee Count

1996 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-27	2025-12-31	19	-2	-9.52%
2025-03-27	2024-12-31	21	-5	-19.23%
2024-04-01	2023-12-31	26	+4	+18.18%
2023-03-31	2022-12-31	22	+1	+4.76%
2022-03-31	2021-12-31	21	+0	+0.00%
2021-03-31	2020-12-31	21	-3	-12.50%
2020-03-30	2019-12-31	24	-7	-22.58%
2019-04-01	2018-12-31	31	+6	+24.00%
2018-03-30	2017-12-31	25	-7	-21.88%
2017-03-31	2016-12-31	32	+2	+6.67%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

AIM ImmunoTech Inc.YOU

19$2M #3

ENSC

Ensysce Biosciences, Inc.

7$2M #4

CANF

Can-Fite BioPharma Ltd.

5$2M #5

KTTA

Pasithea Therapeutics Corp.

Quoin Pharmaceuticals, Ltd.

3$3M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AIM peer comparison

About AIM employees

AIM Employees · Headcount

AIM ImmunoTech Inc. (AIM) employee data is sourced from the annual SEC 10-K filing. As of 2025, AIM ImmunoTech Inc. had 19 full-time employees globally. Full-time employees only. Global consolidated headcount.

AIM ImmunoTech Inc. employs 19 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $4,632, reflecting the company's operational efficiency.

AIM ImmunoTech Inc.'s workforce decreased by 2 (9.52%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

AIM ImmunoTech Inc.'s revenue per employee of $4,632 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

AIM Employees · 5 questions

As of the latest SEC 10-K filing (2025), AIM ImmunoTech Inc. had 19 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

AIM ImmunoTech Inc. employee counthow many employees does AIM ImmunoTech Inc. haveAIM total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-27